Multiple Sclerosis at the Limits is supported by way of grants or sponsorship from the pharmaceutical industry. Our supporters have no involvement in the organisation of this event, or the selection of speakers or topics which are handled entirely independently by the event Chairs. Supporters are invited to send a delegation of senior company representatives to attend, and their role is simply to continue building the crucial understanding between academia and industry in a scientific setting. Full disclosure of contacted supporters will appear on the event website and be available at the venue during the event. + Include: 13 videos + 1 pdf, size: 5.61 GB + Sample video: contact me for sample video The Royal College of Physicians, London Tuesday, 26 & Wednesday, 27 September 2023 About the event The 6th Annual MS conference is a two-day medical education meeting which brings together a notable faculty of globally acknowledged MS experts who will consider new discoveries and therapies at the limits of MS treatments.Audience: Multiple Sclerosis Specialists, Neurologists, Rehabilitation Specialists, Immunologists, Neurophysiologists, Scientists, Researchers. Funders Multiple Sclerosis at the Limits is supported by way of grants or sponsorship from the pharmaceutical industry. Our supporters have no involvement in the organisation of this event, or the selection of speakers or topics which are handled entirely independently by the event Chairs. Supporters are invited to send a delegation of senior company representatives to attend, and their role is simply to continue building the crucial understanding between academia and industry in a scientific setting. Full disclosure of contacted supporters will appear on the event website and be available at the venue during the event. + Topics: Multiple Sclerosisÿat the Limits.pdf Associate Professor M Isabel Leite – Long-term treatment of NMOSD – what do we need to know to make meaningful decisions-.mp4 Debate – DMT’s for all at diagnosis.mp4 Dirk Smeets – Demystifying AI and embedding it into clinical practice.mp4 Dr Arman Eshaghi – Redefining disease phenotyping in MS – basic science.mp4 Panel discussion – Emerging therapies in MS.mp4 Professor Alberto Ascherio – EBV in MS – still in focus, or soon forgotten (again)-.mp4 Professor Anat Achiron – DMT in newly diagnosed people with MS – coaching or coaxing.mp4 Professor David Baker – Beyond B-Cells – selective targeting of B-cell subpopulations.mp4 Professor Francisco J. Quintana – Cell-Cell signalling pathways- microglia and activated astrocytes.mp4 Professor Gavin Giovannoni – Redefining disease cell-typing in MS – clinical.mp4 Professor Jacqueline Palace – Long-term treatment of MOG AD – what do we need to know to make meaningful decisions.mp4 Professor Magd Zakaria – Treating MS Globally – the challenge of equity in MS care.mp4 Univ. Prof. Dr. Med. Heinz Wiendl – Immunopathogenic Mechanisms.mp4
